Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch- Schönlein purpura (IgA vasculitis).

Autor: López-Mejías, Raquel, Genre, Fernanda, Remuzgo-Martínez, Sara, Pérez, Belén Sevilla, Castañeda, Santos, Llorca, Javier, Ortego-Centeno, Norberto, Ubilla, Begoña, Mijares, Verónica, Pina, Trinitario, Calvo-Río, Vanesa, Palmou, Natalia, Miranda-Filloy, José A., Parejo, Antonio Navas, Argila, Diego, Sánchez-Pérez, Javier, Rubio, Esteban, Luque, Manuel León, Blanco-Madrigal, Juan María, Galíndez-Aguirregoikoa, Eva

Publikováno v: Arthritis Research & Therapy; 10/13/2015, Vol. 17, p1-8, 8p

Brief Report: Association of HLA-DRB1*01 With IgA Vasculitis (Henoch-Schönlein)

Autor: López-Mejías, Raquel, Genre, Fernanda, Pérez, Belén Sevilla, Castañeda, Santos, Ortego-Centeno, Norberto, Llorca, Javier, Ubilla, Begoña, Remuzgo-Martínez, Sara, Mijares, Verónica, Pina, Trinitario, Calvo-Río, Vanesa, Márquez, Ana, Sala-Icardo, Luis, Miranda-Filloy, José A., Conde-Jaldón, Marta, Ortiz-Fernández, Lourdes, Rubio, Esteban, Luque, Manuel León, Blanco-Madrigal, Juan M., Galíndez-Aguirregoikoa, Eva

Publikováno v: Arthritis & Rheumatology; Mar2015, Vol. 67 Issue 3, p823-827, 5p

Author Correction: BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis.

Autor: Prieto-Peña D; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain., Genre F; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain., Remuzgo-Martínez S; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain., Pulito-Cueto V; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain., Atienza-Mateo B; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain.; `López Albo´ Post-Residency Programme, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Llorca J; Epidemiology and Computational Biology Department, School of Medicine, Universidad de Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), Santander, Spain., Sevilla-Pérez B; Division of Paediatrics, Hospital Universitario San Cecilio, Granada, Spain., Ortego-Centeno N; Medicine Department, Universidad de Granada, Granada, Spain., Lera-Gómez L; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain., Leonardo MT; Division of Paediatrics, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Peñalba A; Division of Paediatrics, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Narváez J; Division of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain., Martín-Penagos L; Division of Nephrology, Hospital Universitario Marqués de Valdecilla, IDIVAL-REDINREN, Santander, Spain., Rodrigo E; Division of Nephrology, Hospital Universitario Marqués de Valdecilla, IDIVAL-REDINREN, Santander, Spain., Miranda-Filloy JA; Division of Rheumatology, Hospital Universitario Lucus Augusti, Lugo, Spain., Caminal-Montero L; Internal Medicine Dept., Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain., Collado P; Division of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain., Pérez JS; Division of Dermatology, Hospital Universitario de La Princesa, Madrid, Spain., Argila D; Division of Dermatology, Hospital Universitario de La Princesa, Madrid, Spain., Rubio E; Division of Rheumatology, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Luque ML; Division of Rheumatology, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Blanco-Madrigal JM; Division of Rheumatology, Hospital Universitario de Basurto, Bilbao, Spain., Galíndez-Agirregoikoa E; Division of Rheumatology, Hospital Universitario de Basurto, Bilbao, Spain., Gualillo O; SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), NEIRID Lab (Neuroendocrine Interactions in Rheumatology and Infammatory Diseases), Research Laboratory 9, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain., Martín J; Instituto de Parasitología y Biomedicina 'López-Neyra', CSIC, PTS Granada, Granada, Spain., Castañeda S; Rheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain., Blanco R; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain., González-Gay MA; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain.; School of Medicine, Universidad de Cantabria, Santander, Spain.; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., López-Mejías R; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, 39011, Santander, Spain. rlopezmejias78@gmail.com.

Publikováno v: Scientific reports [Sci Rep] 2021 Aug 16; Vol. 11 (1), pp. 16946. Date of Electronic Publication: 2021 Aug 16.

Interleukin 1 beta (IL1ß) rs16944 genetic variant as a genetic marker of severe renal manifestations and renal sequelae in Henoch-Schönlein purpura.

Autor: López-Mejías R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain., Genre F; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain., Remuzgo-Martínez S; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain., Sevilla Pérez B; Medicine Department, Hospital Universitario San Cecilio, Granada, Spain., Castañeda S; Rheumatology Department, Hospital Universitario La Princesa, IIS-Princesa, Madrid, Spain., Llorca J; Epidemiology and Computational Biology Department, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain., Ortego-Centeno N; Medicine Department, Hospital Universitario San Cecilio, Granada, Spain., Ubilla B; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain., Mijares V; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain., Pina T; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain., Calvo-Río V; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain., Miranda-Filloy JA; Division of Rheumatology, Hospital Universitario Lucus Augusti, Lugo, Spain., Navas Parejo A; Nephrology Department, Hospital Universitario San Cecilio, Granada, Spain., Argila D; Dermatology Department, Hospital Universitario La Princesa, IIS-Princesa, Madrid, Spain., Sánchez-Pérez J; Dermatology Department, Hospital Universitario La Princesa, IIS-Princesa, Madrid, Spain., Rubio E; Rheumatology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Luque ML; Rheumatology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Blanco-Madrigal JM; Rheumatology Department, Hospital Universitario de Basurto, Bilbao, Spain., Galíndez-Aguirregoikoa E; Rheumatology Department, Hospital Universitario de Basurto, Bilbao, Spain., Martín J; Institute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain., Blanco R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain., González-Gay MA; Epidemiology, Genetics & Atherosclerosis Res.Group, Systemic Inflammatory Diseases, IDIVAL; School of Medicine, Univ.of Cantabria, Santander, Spain; and Cardiovascular Pathophysiology & Genomics Research, Univ.of Witwatersrand, Johannesburg, South Africa.

Publikováno v: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2016 May-Jun; Vol. 34 (3 Suppl 97), pp. S84-8. Date of Electronic Publication: 2016 Feb 01.